Prostaglandins
Products Related to Prostaglandins(462)
- GC405898-iso-15(R)-Prostaglandin F2αCAS: 214748-65-9Purity: >98.00%
8-iso-15(R) PGF2α is one member of a large family of prostaglandin-like eicosanoids formed by the free radical peroxidation of arachidonic acid in membrane phospholipids.
- GC40592Prostaglandin F2β MaxSpec® StandardCAS: 4510-16-1Purity: 99.00%
Prostaglandin F2β (PGF2β) is the 9β-hydroxy stereoisomer of PGF2α.
- GC4060515-keto Prostaglandin E2CAS: 26441-05-4Purity: >98.00%
15-keto Prostaglandin E2 (15-keto PGE2) is a metabolite of PGE2 formed by 15-hydroxy PGDH.
- GC4060615-keto Prostaglandin E2 MaxSpec® StandardCAS: 26441-05-4Purity: >98.00%
15-keto Prostaglandin E2 (15-keto PGE2) is a metabolite of PGE2 formed by 15-hydroxy PGDH.
- GC40610Prostaglandin D3CAS: 71902-47-1Purity: >98.00%
Prostaglandin D3 (PGD3) is produced by the metabolism of EPA via the COX pathway.
- GC40611Prostaglandin E3CAS: 802-31-3Purity: >98.00%
Prostaglandin E3 (PGE3) is formed via the cyclooxygenase (COX) metabolism of eicosapentaenoic acid.
- GC4062513,14-dihydro-15-keto-tetranor Prostaglandin D2CAS: 1204116-69-7Purity: >95.00%
A common metabolic pathway for several prostaglandins (PGs), including PGD2, involves the reduction of the double bond between C-13 and C-14 and oxidation of the hydroxyl group at C-15, producing 13,14-dihydro-15-keto PGs.
- GC4062613,14-dihydro-15-keto-tetranor Prostaglandin E2CAS: 20675-85-8Purity: >95.00%
A common metabolic pathway for several prostaglandins (PG), including PGE2, involves the reduction of the double bond between C-13 and C-14 and oxidation of the hydroxyl group at C-15, producing 13,14-dihydro-15-keto PGs.
- GC4064815(R)-17-phenyl trinor Prostaglandin F2α ethyl amideCAS: 1163135-92-9Purity: >98.00%
15(R)-17-phenyl trinor Prostaglandin F2α ethyl amide (15(R)-17-phenyl trinor PGF2α ethyl amide) is an isomer of bimatoprost, characterized by an inverted (β) hydroxyl group at C-15.
- GC40716(R)-ButaprostCAS: 69648-38-0Purity: >98.00%
Butaprost is a structural analog of prostaglandin E2 (PGE2) with good selectivity for the EP2 receptor subtype.
- GC4074513,14-dehydro-15-cyclohexyl CarbaprostacyclinCAS: 145375-81-1Purity: >98.00%
13,14-dehydro-15-cyclohexyl Carbaprostacyclin is a chemically stable analog of PGI2.
- GC4076216-phenoxy Prostaglandin F2α ethyl amideCAS: 951319-59-8Purity: >98.00%
Prostaglandin F2α (PGF2α), acting through the FP receptor, causes smooth muscle contraction and exhibits potent luteolytic activity.
- GC40765Prostaglandin A3CAS: 36614-31-0Purity: >98.00%
Cyclooxygenase metabolism of EPA to produce Prostaglandin E3 (PGE3) has been reported in biosynthetic preparations of ovine seminal vesicles and in the ocular tissues of primates.
- GC40766Prostaglandin B3CAS: 36614-32-1Purity: >97.00%
Prostaglandin B3 (PGB3) is a non-enzymatic dehydration product resulting from the treatment of Prostaglandin E3 (PGE3) with strong base.
- GC40814Heneicosapentaenoic Acid methyl esterCAS: 65919-53-1Purity: >98.00%
Heneicosapentaensäure (HPA) ist eine Fettsäure, die in geringen Mengen in der grünen Alge Bryopsis pennata Lamouroux und in Fischölen vorkommt.
- GC40866Tafluprost (free acid)CAS: 209860-88-8Purity: >98.00%
Tafluprost (freie SÄure) (AFP-172), eine aktive metabolische Form von Tafluprost, ist ein selektiver Prostanoid-FP-Rezeptoragonist.
- GC4096116-phenoxy tetranor Prostaglandin F2α methyl esterCAS: 51638-90-5Purity: >98.00%
Prostaglandin F2α (PGF2α) drives luteolysis and smooth muscle contraction by activating the FP receptor.
- GC4096217-phenoxy trinor Prostaglandin F2αCAS: 2162157-41-5Purity: >98.00%
17-phenoxy trinor prostaglandin F2α (17-phenoxy trinor PGF2α) is a novel analog of PGF2α.
- GC409765-cis IloprostCAS: 82889-99-4Purity: >97.00%
5-cis Iloprost is the C-5 cis-isomer of iloprost, a second generation structural analog of prostaglandin I2 (prostacyclin).
- GC409775-cis-15(R)-IloprostPurity: >97.00%
5-cis-15(R)-Iloprost is the C-5 cis-isomer and 15(R)-epimer of iloprost, a second generation structural analog of prostaglandin I2 (prostacyclin).
- GC4098815(R)-17-phenyl trinor Prostaglandin F2αCAS: 41639-71-8Purity: >98.00%
17-phenyl trinor Prostaglandin F2α N-ethyl amide (17-phenyl trinor PGF2α) is an F-series prostaglandin analog which has been approved for use as an ocular hypotensive drug, sold under the Allergan trade name 17-phenyl trinor PGF2α ethyl amide.
- GC4099017-phenyl trinor Prostaglandin F2αCAS: 38344-08-0Purity: >98.00%
17-phenyl trinor Prostaglandin F2α (17-phenyl trinor PGF2α) is a metabolically stable analog of PGF2α and is a potent agonist for the FP receptor.
- GC409918-iso-17-phenyl trinor Prostaglandin F2αPurity: >98.00%
8-iso-17-phenyl trinor Prostaglandin F2α (8-iso-17-phenyl trinor PGF2α) is the C-8 epimer of bimatoprost (free acid), a metabolically stable analog of PGF2α.
- GC409928-iso-17-phenyl trinor Prostaglandin F2βPurity: >98.00%
Bimatoprost (free acid) is a metabolically stable analog of prostaglandin F2α (PGF2α) and a potent agonist for the FP receptor.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC40589 | 8-iso-15(R)-Prostaglandin F2α | 214748-65-9 | >98.00% | |
8-iso-15(R) PGF2α is one member of a large family of prostaglandin-like eicosanoids formed by the free radical peroxidation of arachidonic acid in membrane phospholipids. | ||||
| GC40592 | Prostaglandin F2β MaxSpec® Standard | 4510-16-1 | 99.00% | |
Prostaglandin F2β (PGF2β) is the 9β-hydroxy stereoisomer of PGF2α. | ||||
| GC40605 | 15-keto Prostaglandin E2 | 26441-05-4 | >98.00% | |
15-keto Prostaglandin E2 (15-keto PGE2) is a metabolite of PGE2 formed by 15-hydroxy PGDH. | ||||
| GC40606 | 15-keto Prostaglandin E2 MaxSpec® Standard | 26441-05-4 | >98.00% | |
15-keto Prostaglandin E2 (15-keto PGE2) is a metabolite of PGE2 formed by 15-hydroxy PGDH. | ||||
| GC40610 | Prostaglandin D3 | 71902-47-1 | >98.00% | |
Prostaglandin D3 (PGD3) is produced by the metabolism of EPA via the COX pathway. | ||||
| GC40611 | Prostaglandin E3 | 802-31-3 | >98.00% | |
Prostaglandin E3 (PGE3) is formed via the cyclooxygenase (COX) metabolism of eicosapentaenoic acid. | ||||
| GC40625 | 13,14-dihydro-15-keto-tetranor Prostaglandin D2 | 1204116-69-7 | >95.00% | |
A common metabolic pathway for several prostaglandins (PGs), including PGD2, involves the reduction of the double bond between C-13 and C-14 and oxidation of the hydroxyl group at C-15, producing 13,14-dihydro-15-keto PGs. | ||||
| GC40626 | 13,14-dihydro-15-keto-tetranor Prostaglandin E2 | 20675-85-8 | >95.00% | |
A common metabolic pathway for several prostaglandins (PG), including PGE2, involves the reduction of the double bond between C-13 and C-14 and oxidation of the hydroxyl group at C-15, producing 13,14-dihydro-15-keto PGs. | ||||
| GC40648 | 15(R)-17-phenyl trinor Prostaglandin F2α ethyl amide | 1163135-92-9 | >98.00% | |
15(R)-17-phenyl trinor Prostaglandin F2α ethyl amide (15(R)-17-phenyl trinor PGF2α ethyl amide) is an isomer of bimatoprost, characterized by an inverted (β) hydroxyl group at C-15. | ||||
| GC40716 | (R)-Butaprost | 69648-38-0 | >98.00% | |
Butaprost is a structural analog of prostaglandin E2 (PGE2) with good selectivity for the EP2 receptor subtype. | ||||
| GC40745 | 13,14-dehydro-15-cyclohexyl Carbaprostacyclin | 145375-81-1 | >98.00% | |
13,14-dehydro-15-cyclohexyl Carbaprostacyclin is a chemically stable analog of PGI2. | ||||
| GC40762 | 16-phenoxy Prostaglandin F2α ethyl amide | 951319-59-8 | >98.00% | |
Prostaglandin F2α (PGF2α), acting through the FP receptor, causes smooth muscle contraction and exhibits potent luteolytic activity. | ||||
| GC40765 | Prostaglandin A3 | 36614-31-0 | >98.00% | |
Cyclooxygenase metabolism of EPA to produce Prostaglandin E3 (PGE3) has been reported in biosynthetic preparations of ovine seminal vesicles and in the ocular tissues of primates. | ||||
| GC40766 | Prostaglandin B3 | 36614-32-1 | >97.00% | |
Prostaglandin B3 (PGB3) is a non-enzymatic dehydration product resulting from the treatment of Prostaglandin E3 (PGE3) with strong base. | ||||
| GC40814 | Heneicosapentaenoic Acid methyl ester | 65919-53-1 | >98.00% | |
Heneicosapentaensäure (HPA) ist eine Fettsäure, die in geringen Mengen in der grünen Alge Bryopsis pennata Lamouroux und in Fischölen vorkommt. | ||||
| GC40866 | Tafluprost (free acid) | 209860-88-8 | >98.00% | |
Tafluprost (freie SÄure) (AFP-172), eine aktive metabolische Form von Tafluprost, ist ein selektiver Prostanoid-FP-Rezeptoragonist. | ||||
| GC40961 | 16-phenoxy tetranor Prostaglandin F2α methyl ester | 51638-90-5 | >98.00% | |
Prostaglandin F2α (PGF2α) drives luteolysis and smooth muscle contraction by activating the FP receptor. | ||||
| GC40962 | 17-phenoxy trinor Prostaglandin F2α | 2162157-41-5 | >98.00% | |
17-phenoxy trinor prostaglandin F2α (17-phenoxy trinor PGF2α) is a novel analog of PGF2α. | ||||
| GC40976 | 5-cis Iloprost | 82889-99-4 | >97.00% | |
5-cis Iloprost is the C-5 cis-isomer of iloprost, a second generation structural analog of prostaglandin I2 (prostacyclin). | ||||
| GC40977 | 5-cis-15(R)-Iloprost | - | >97.00% | |
5-cis-15(R)-Iloprost is the C-5 cis-isomer and 15(R)-epimer of iloprost, a second generation structural analog of prostaglandin I2 (prostacyclin). | ||||
| GC40988 | 15(R)-17-phenyl trinor Prostaglandin F2α | 41639-71-8 | >98.00% | |
17-phenyl trinor Prostaglandin F2α N-ethyl amide (17-phenyl trinor PGF2α) is an F-series prostaglandin analog which has been approved for use as an ocular hypotensive drug, sold under the Allergan trade name 17-phenyl trinor PGF2α ethyl amide. | ||||
| GC40990 | 17-phenyl trinor Prostaglandin F2α | 38344-08-0 | >98.00% | |
17-phenyl trinor Prostaglandin F2α (17-phenyl trinor PGF2α) is a metabolically stable analog of PGF2α and is a potent agonist for the FP receptor. | ||||
| GC40991 | 8-iso-17-phenyl trinor Prostaglandin F2α | - | >98.00% | |
8-iso-17-phenyl trinor Prostaglandin F2α (8-iso-17-phenyl trinor PGF2α) is the C-8 epimer of bimatoprost (free acid), a metabolically stable analog of PGF2α. | ||||
| GC40992 | 8-iso-17-phenyl trinor Prostaglandin F2β | - | >98.00% | |
Bimatoprost (free acid) is a metabolically stable analog of prostaglandin F2α (PGF2α) and a potent agonist for the FP receptor. | ||||
